Seeking Alpha
14 Jul 2026, 01:20 UTC · 15w ago
Lineage Cell Therapeutics, Inc. (LCTX) Discusses COR1 Cell Transplant Program and Manufacturing Strategy for Corneal Endothelial Disease Transcript
Verdict
Headline takes no side. We score LCTX +0.30 — moderately bullish.
- Expected · LCTX
+0.30moderately bullish
−1 bearish0bullish +1More positive than 59% of ticker scores this week





